SCHEMBL7524860

SCHEMBL7524860

O=C(O)c1cc(O)c2c(Cl)cccc2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
TSHR P16473 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
IGFBP3 P17936 2/20 0.44
DHODH Q02127 1/20 0.44
MGAM O43451 1/20 0.42
ALOX15 P16050 3/20 0.42
ACMSD Q8TDX5 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
IGFBP5 P24593 1/20 0.41
HPGD P15428 1/20 0.41
CLK1 P49759 1/20 0.40
CDK9 P50750 1/20 0.40
CDK5 Q00535 1/20 0.40
DYRK1A Q13627 1/20 0.40
DYRK2 Q92630 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9768818 0.88 DHODH (0.47) KDM4ETSHRALDH1A1HSD17B10KMT2A
SCHEMBL9398456 0.86 GRM2 (0.46) DHODHPARP1NQO2
SCHEMBL2908140 0.85 KDM4E (0.46) KDM4ETSHRALDH1A1HSD17B10KMT2A
SCHEMBL11668909 0.84 ALDH1A1 (0.47) KDM4ETSHRALDH1A1HSD17B10KMT2A
SCHEMBL9441962 0.83 DHODH (0.43) KDM4ETSHRALDH1A1HSD17B10KMT2A
SCHEMBL29384232 0.82 IGFBP3 (0.41) TSHRKMT2AMEN1IGFBP3MGAM
SCHEMBL158714 0.82 IGFBP3 (0.41) TSHRKMT2AMEN1IGFBP3MGAM
SCHEMBL9379118 0.82 NQO2 (0.51) KDM4ETSHRALDH1A1HSD17B10HPGD
SCHEMBL3328166 0.81 MGAM (0.42) KDM4ETSHRALDH1A1HSD17B10KMT2A
SCHEMBL2910010 0.81 MGAM (0.42) KDM4ETSHRALDH1A1HSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6465653-B2 HEATING AND HYDROLYZING/DECARBOXYLATING 4-HYDROXYQUINOLINE CARBOXYLIC ACID ESTER IN PRESENCE OF WATER IN LIQUID OR VAPOR PHASE; PLANT SAFENING AGENTS RHODIA CHIMIE (FR) 2002-10-15 US claimed
US-20020007067-A1 Noncatalyzed synthesis of 4-hydroxyquinolines and/or tautomers thereof RHODIA CHIMIE (FR) 2002-01-17 US claimed
US-6465653-B2 HEATING AND HYDROLYZING/DECARBOXYLATING 4-HYDROXYQUINOLINE CARBOXYLIC ACID ESTER IN PRESENCE OF WATER IN LIQUID OR VAPOR PHASE; PLANT SAFENING AGENTS RHODIA CHIMIE (FR) 2002-10-15 US disclosed
US-20020007067-A1 Noncatalyzed synthesis of 4-hydroxyquinolines and/or tautomers thereof RHODIA CHIMIE (FR) 2002-01-17 US disclosed
US-5344922-A 4-hydroxyquinaldic acid derivatives BOARD OF REGENTS, UNIVERSITY OF TEXAS 1994-09-06 US disclosed
US-5028707-A 4-hydroxyquinaldic acid derivatives BOARD OF REGENTS, UNIVERSITY OF TEXAS (US) 1991-07-02 US disclosed
WO-1991007390-A1 4-HYDROXYQUINALDIC ACID DERIVATIVES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1991-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007067-A1 Noncatalyzed synthesis of 4-hydroxyquinolines and/or tautomers thereof HAAO, HPD, HAO2 KDM4E 868/4885TSHR 4505/4885ALDH1A1 619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.